Close Menu


Under the deal, Biosearch has the exclusive rights to manufacture, catalogue, and sell validated RNA FISH probes, assays, and kits in the research, applied markets, and in vitro diagnostic fields.

Product Watch


Cepheid's GeneXpert Infinity-48 system; Biosearch's influenza ValuPanel reagents; Bibby Scientific's Techne TC-PLUS thermal cyclers; Embark Scientific nucleic acid for sulfur-reducing and –oxidizing bacteria

Under the new license with Roche, Biosearch now has the right to manufacture and sell validated kits, including probes, primers, enzymes, and other essential nucleic acid amplification technologies.

The license will expand Biosearch's participation in the diagnostics field from a provider of oligo components to a provider of kits.

Biosearch and Eurofins MWG Operon, its co-defendant on the case, also requested that the suit be transferred from the US District Court in Eastern Texas to the Northern District of California.

Patents awarded to Gen-Probe, Quest Diagnostics, Biosearch Technologies, and more.

Biosearch said it is the first to license the CDC influenza signatures, and that it will manufacture and sell oligonucleotides bearing the H1N1 and influenza A sub-typing signatures.

The license gives Micronics the rights to use and sell molecular diagnostic technologies using Biosearch's fluorophores and quencher dyes.

Biosearch will develop rapid, multiplexed fluorescent assays for identifying bioterror and food safety pathogens.

Biosearch licensed the rights to Roche patents for use of oligo probes.


Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.